References
- MMWR. Surveillance summaries. Morb Mort Wkly Rep August 2, 2002; 51(No. SS‐6)
- Collins J G. Prevalence of selected chronic conditions: United States, 1990–92; National Center for Health Statistics. Vital Health Stat 1997; 10(194)12–13
- Lacasse Y, Brooks D, Goldstein R S. Trends in the epidemiology of COPD in Canada, 1980 to 1995. COPD and Rehabilitation Committee of the Canadian Thoracic Society. Chest 1999; 116: 306–313, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Pauwels R A, Lofdahl C G, Laitinen L A, Schouten J P, Postma D S, Pride N B, Ohlsson S V, for the European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. Long‐term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. N Engl J Med 1999; 340: 1948–1953, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Burge P S, Calverley P M, Jones P W, Spencer S, Anderson J A, Maslen T K. Randomized, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000; 320: 1297–1303, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Vestbo J, Sorensen T, Lange P, Brix A, Torre P, Viskum K. Long‐term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomized controlled trial. Lancet 1999; 353: 1819–1823, [PUBMED], [INFOTRIEVE], [CROSSREF]
- The Lung Health Study Research Group. Effect of inhaled triamcinolone on the decline of pulmonary function in chronic obstructive pulmonary disease. N Engl J Med 2000; 343: 1902–1909, [CROSSREF], [CSA]
- Barnes P J. Chronic obstructive pulmonary disease. N Engl J Med 2000; 343: 269–280, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Davies L, Angus R M, Calverley P M. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Lancet 1999; 354: 456–460, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Niewoehner D E, Erbland M L, Deupree R H, Collin S D, Gross N J, Light R W, Anderson P, Morgan N A. The Department of Veterans Affairs Cooperative Study. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1999; 340: 1941–1947, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Calverley P, Pauwels R, Vestbo J, et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2003; 361: 449–456, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Sin D D, Tu J V. Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 580–584, [PUBMED], [INFOTRIEVE], [CSA]
- Soriano J B, Vestbo J, Pride N B, Kiri V, Maden C, Maier W C. Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice. Eur Respir J 2002; 20: 819–825, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Fan V S, Bryson C L, Curtis J R, Fihn S D, Bridevaux P O, McDonell M B, Au D H. Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalization: time‐dependent analysis. Am J Respir Crit Care Med 2003; 168: 1488–1494, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Bourbeau J, Ernst P, Cockcoft D, Suissa S. Inhaled corticosteroids and hospitalisation due to exacerbation of COPD. Eur Respir J 2003; 22: 286–289, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Suissa S. Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease. Am J Resp Crit Care Med 2003; 168: 49–53, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Symmetry Health Data Systems. Episode Treatment Groups Users Guide: Release 4.3. Symmetry Health Data Systems, Phoenix, AZ 2002
- Stempel D A, McLaughlin T P, Griffis D L, Stanford R H. Cost analysis of the use of inhaled corticosteroids in the treatment of asthma: a 1‐year follow‐up. Respir Med 2001; 95(12)992–998, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Yazdani C, McLaughlin T P, Smeeding J, Walt J. Prevalence of treated eye disease in a managed care population. Clin Ther 2001; 23(10)1672–1682, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lee J, Cummins G, Okamoto L. A descriptive analysis of the use and cost of new‐generation antihistamines in the treatment of allergic rhinitis: a retrospective database analysis. Am J Managed Care 2001; 7(suppl 4)S103–S112, [CSA]
- Department of Health and Human Services. The international classification of diseases, 9th rev. Clinical Modification: ICD‐9‐CM. Vol. 1. Diseases: Alphabetic Index2nd ed. Department of Health and Human Services, Washington, DC 1980
- Paggiaro P L, Dahle R, Bakran I, Frith L, Hollingworth K, Efthiniou J, on behalf of the International COPD Study Group. Multicentre randomized placebo‐controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disorder. Lancet 1998; 351: 773–780, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Anthonisen N R, Wright E C, Hodgkin J E. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 133: 14–20, [PUBMED], [INFOTRIEVE]
- Mahler D A, Donohue J F, Barbee R A, Goldman M D, Gross N J, Wisniewski M E, Yancey S W, Zakes B A, Rickard K A, Anderson W H. Efficacy of salmeterol xinafoate in the treatment of COPD. Chest 1999; 115: 957–965, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Strassels S A, Smith D H, Sullivan S D, Mahajan P S. The costs of treating COPD in the United States. Chest 2001; 119: 344–352, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Guite H F, Dundas R, Burney P G. Risk factors for death from asthma, chronic obstructive pulmonary disease, and cardiovascular disease after a hospital admission for asthma. Thorax 1999; 54(4)301–307, [PUBMED], [INFOTRIEVE]
- Wen S W, Hernandez R, Naylor C D. Pitfalls in nonrandomized outcomes studies. The case of incidental appendectomy with open cholecystectomy. JAMA 1995; 274: 1687–1691, [PUBMED], [INFOTRIEVE], [CROSSREF]
- D'Hoore W, Bouckaert A, Tilquin C. Practical considerations on the use of the Charlson comorbidity index with administrative databases. J Clin Epidemiol 1996; 49: 1429–1433, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sin D D, Tu J V. Lack of association between ipratropium bromide and mortality in elderly patients with chronic obstructive airway disease. Thorax 2000; 55: 194–197, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Benson K, Hartz A J. A comparison of observational studies and randomized, controlled trials. N Engl J Med 2000; 342: 1878–1886, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Concato J, Shah N, Horwitz R I. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000; 342: 1887–1892, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]